Berlin, Germany:
German company BioNTech said Friday a preliminary study shows that its vaccine works against the key mutation in coronavirus variants uncovered in Britain and South Africa which experts have said is more contagious than the original Covid-19 strain.
Tests carried out have shown that "antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively neutralise SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains," said the German company of the vaccine it developed with US group Pfizer.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
COMMENTS
Advertisement
UK Airports, Trains, London Stock Exchange, NHS Impacted By Global IT Outage Riots Break Out In London, Bus Set On Fire, Police Car Flipped Over UK Covid-19 Inquiry To Issue First Report On Preparedness Israeli Jets Strike Yemen Rebels After Deadly Attack On Tel Aviv Woman On Scooter With 2 Kids Punched, Left Bleeding In Pune Road Rage Case The 'Fake' CrowdStrike Worker Who Took Credit For Biggest-Ever IT Outage At Least 39 Palestinians Killed As Israel Steps Up Gaza Bombardment Donald Trump's Former Physician Shares New Details On Gunshot Wound Israel Strikes Hezbollah Ammunition Depot In Lebanon, 4 Wounded: Report Track Latest News Live on NDTV.com and get news updates from India and around the world.